Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADV7103 effect on gastric pH in healthy adults
NCT07446881Phase 1Completed
- Sponsor
- Advicenne
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Sibnayal in distal renal tubular acidosis (dRTA), sponsored by Advicenne. Primary endpoint: Effect of ADV7103 on gastric pH at 4 days. Started Feb 2025; status: completed.
02
Drugs
Sibnayal
03
Conditions
distal renal tubular acidosis (dRTA)
Beyond the preview
Go deeper on NCT07446881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07446881.